Alternaturals, Inc. (OTCPINK: ANAS) saw its share volume skyrocket on May 22nd with 256,272,344 shares exchanging hands, eight times higher than its three month daily average volume of 31,320,703 shares.
This uptick in volume comes after Alternaturals announced that it has already started shipping products out to third party retailers, and there are distribution deals in place that will have its highly anticipated medical marijuana product, five hour high, hitting dispensary shelves in as little as four weeks.
The company confirms that this week products began to ship to globally recognized retailer Amazon.com. The company will not just sell products through Amazon using its Amazon storefront to sell its goods direct, which is something anyone can do, but the company also has a deal in place to ship wholesale products to Amazon's warehouses, where the online retail giant will sell the products in their own categories. This offers far more exposure for the first two products in the line, Sombium and Focamine, and is coupled with an advertising plan to drive additional traffic using online ads throughout the site. With a long list of brick and mortar, and online retailers already on board, Alternaturals has plans to announce each deal as they roll out.
Company CEO, Mr. Gyamfi explained, "I know the public is very anxious to know all about the many deals we have already, and the new ones we have in the works, but we have to respect our partners and put out information in a professional and restrained manner. I would love to list all the companies we are partnered with right now because it would really highlight just how far we have come, but the last thing I want to do is overburden valuable partners with shareholder inquires that could jeopardize our relationships. I promise everyone that they will come in due time, and when appropriate."
ANAS closed the day at $.0059, 89.66% higher than its previous close of $.0029.
PennyPickAlerts.com is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:
Invent Ventures Portfolio Company Secures Agreement With May Clinic Bioservices
Invent Ventures, Inc. (OTCQB: IDEA) saw its share volume surge on May 22nd with 1,971,584 shares exchanging hands, nearly 70 times higher than its three month daily average volume of 28,172 shares.
Invent Ventures supplies portfolio companies with the capital to cultivate their initial product, and provide hands-on support services to reduce startup costs and accelerate time to market. INVENT services include product development and design, corporate formation and structure, and exposure to additional financing.
This recent jump in volume comes after Invent Ventures announced that its portfolio company Sanguine Biosciences, Inc. ("Sanguine") has secured an agreement with Mayo Clinic Bioservices.
Under this agreement, Mayo Clinic Bioservices will process, store and ship biospecimens collected by Sanguine for the purpose of developing new therapies. Mayo Clinic Bioservices will provide integrated laboratory services including specimen accessioning, processing, nucleic acid extraction, specimen tracking, storage and shipping. Mayo Clinic Bioservices is a new service from the Mayo Clinic Center for Individualized Medicine.
"Partnering with Mayo Clinic Bioservices dramatically increases the scalability of the Sanguine's business and furthers the company in its goal of improving efficiency in the development of personalized medical research," said Bryce Knight, CEO of INVENT Ventures. "Not only does this partnership benefit Sanguine and its clients which include 20 of the top 40 pharmaceutical and biotechnology companies, but more importantly it allows patients on its waiting list to participate in the research and development of new treatments."
IDEA closed the day at $.315, 45% higher than its previous close of $.20.
Medient Studios Announces Commencement of Drilling
Medient Studios, Inc. (OTCQB: MDNT) saw its share volume explode on May 22nd with 167,345,297 shares exchanging hands, over seven times higher than its three month daily average volume of 22,503,888 shares.
This uptick in volume comes after Medient Studios announced the commencement of drilling for the fresh water well. The well is expected to be operational within 280 days.
The existing 155 foot tall water tower can hold up to 500,000 gallons of water. The new well is currently permitted to draw up to 150,000 gallons per day. The well is capable of drawing over 2 million gallons a day.
A locally owned business, PINCO, was awarded the drilling contract. PINCO specializes in water and sewer infrastructure construction.
John Henry of the Effingham County Industrial Development Authority stated, "Drilling this well should allow the studios to get up and running quickly now."
Manu Kumaran, Chairman of the Board of Medient, stated, "Water is the fundamental prerequisite for all other elements of the construction process. We expect to commence work on the roads in the next few days as well."
MDNT closed the day at $.0033, 50% higher than its previous close of $.0022.
Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.
Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.
Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.pennypickalerts.com
Pennypickalerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.